Last edition
News about "Shingrix"
China Approves GSK's Shingrix for Shingles Prevention
The China National Medical Products Administration (NMPA) has approved GSK’s Shingrix (Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.
Shingrix | 15/10/2025 | By Dineshwori | 197
GSK Secures FDA Approval for Prefilled Syringe Version of Shingles Vaccine Shingrix
GSK has received approval from the US Food and Drug Administration (FDA) for a new prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine, RZV), designed to prevent shingles (herpes zoster).
Shingrix | 17/07/2025 | By Dineshwori | 312
GSK introduces Shingrix vaccine in India
Shingrix is the world’s first non-live, recombinant subunit vaccine to be given intramuscularly in two doses
Shingrix | 25/04/2023 | By Sudeep Soparkar | 2034
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy